PathoGene

Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics, Information Technology, Medical Device
Founded in 7/1/20
Los Angeles, California, United States
For Profit

About PathoGene

PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 500000 USD
  • Last Funding: 500000 USD (Seed)
  • Funding Status: Seed

Technology Stack

PathoGene actively uses None products in their tech stack.

Market Presence

Industries: Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics, Information Technology, Medical Device

Headquarters: Los Angeles, California, United States

Employees

  • John Mickel - Cofounder & Chief Visionary Officer (LinkedIn)